Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,980
Closed -$273K 545
2021
Q2
$273K Buy
+2,980
New +$237K 0.02% 402
2021
Q1
Sell
-4,505
Closed -$326K 503
2020
Q4
$326K Buy
+4,505
New +$261K 0.04% 308
2020
Q3
Sell
-6,705
Closed -$238K 421
2020
Q2
$238K Buy
+6,705
New +$191K 0.04% 330
2019
Q3
Sell
-8,205
Closed -$295K 360
2019
Q2
$295K Hold
8,205
0.06% 242
2019
Q1
$259K Hold
8,205
0.05% 286
2018
Q4
$206K Hold
8,205
0.05% 312
2018
Q3
$237K Buy
+8,205
New +$154K 0.05% 322

Other funds holding CDNA

Caprock Group's CDNA Position: Q3 2021 in Review

Caprock Group sold out of CareDx (CDNA) in Q3 2021, closing a stake of 2,980 shares — an estimated $273K sold.

Caprock Group first reported a position in CDNA in Q3 2018 and held it in 7 quarters. The position peaked at $326K in Q4 2020. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Caprock Group reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Caprock Group sold 2,980 CareDx shares in Q3 2021, an estimated $273K.
  • Caprock Group first reported a position in CareDx in Q3 2018 and held it in 7 quarters.
  • Caprock Group's CareDx position peaked at $326K in Q4 2020.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Caprock Group's 13F filing for Q3 2021, filed 7 Oct 2021.